Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4/A Insider Changes in Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award CEO and Director acquired 25,000 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award CEO and Director acquired 10,000 shares (grant or award)
  8. 4 Grant or award Director acquired 10,000 shares (grant or award)
  9. 4 Grant or award Director acquired 10,000 shares (grant or award)
  10. 4 Grant or award Director acquired 10,000 shares (grant or award)
  11. 4 Grant or award Director acquired 10,000 shares (grant or award)
  12. 4 Grant or award Director acquired 10,000 shares (grant or award)
  13. 4 Grant or award Director acquired 10,000 shares (grant or award)
  14. 4 Grant or award Director acquired 10,000 shares (grant or award)
  15. 5 Insider Annual Insider Trading Report
  16. 4 Exercise or conversion Director acquired 54,688 shares (option exercise)
  17. 4 Open-market sale VP, Tech Management sold 700 shares at $4.84 ($3,388)
  18. 4 Open-market sale VP, Tech Management sold 4,300 shares at an average $4.85 ($20,852)
  19. 4 Open-market sale Chief Executive Officer sold 17,900 shares at an average $4.51 ($80,651)
  20. 4 Open-market sale Chief Executive Officer sold 19,900 shares at an average $4.51 ($89,786)

Page 18 of 24 · 475 filings